Ensysce Biosciences
Ensysce Biosciences develops safer prescription drugs using proprietary TAAP and MPAR technology platforms, focusing on tamper-proof treatments for pain to minimize drug abuse and overdose risks.
Company Overview
Ensysce Biosciences develops safer prescription drugs using proprietary TAAP and MPAR technology platforms. Their primary focus is on creating tamper-proof treatment options for pain to minimize the risk of drug abuse and overdose. The company has received FDA 'Fast Track' and 'Breakthrough Therapy' designations for several key product innovations. Additionally, Ensysce Biosciences maintains a comprehensive worldwide patent portfolio that covers a wide array of prescription drug compositions.
Technological Platforms
Ensysce Biosciences leverages its proprietary TAAP and MPAR technology platforms to develop safer prescription drugs. The TAAP platform focuses on tamper-proof formulations, while the MPAR platform is designed to provide overdose protection. These technologies aim to mitigate the risks associated with drug abuse and accidental overdose, making pain treatment safer for patients.
Key Products
Ensysce Biosciences' lead product is PF614, an oxycodone-based pain medication designed for extended release and abuse deterrence. Another key product, PF614-MPAR, combines PF614 with a trypsin inhibitor to offer added protection against overdose. Both products are being advanced through clinical trials, with plans to initiate Phase 3 trials for PF614, aiming for commercialization following FDA review.
Partnerships
Ensysce Biosciences has entered a strategic partnership with OncoZenge AB to co-develop BupiZenge in the United States for treating oral mucositis in cancer patients. This collaboration aims to advance innovative treatments in areas of high unmet medical needs through their combined expertise and resources.
Awards and Grants
Ensysce Biosciences has been awarded approximately $12 million by the National Institute on Drug Abuse to develop its MPAR technology. This significant financial support underscores the potential impact and innovation that Ensysce's technologies could bring to the field of safer pain management.